Legend Biotech Corporation
LEGN
$35.64
-$0.27-0.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 53.18% | 65.84% | 31.65% | 46.43% | 9.94% |
| Total Depreciation and Amortization | 10.18% | 21.12% | 15.11% | 14.88% | 18.34% |
| Total Amortization of Deferred Charges | -17.20% | -53.27% | -50.63% | -49.71% | -61.94% |
| Total Other Non-Cash Items | -39.61% | -99.04% | -39.06% | -72.28% | 130.15% |
| Change in Net Operating Assets | -392.68% | 111.13% | 1,143.87% | 79.61% | -67.89% |
| Cash from Operations | -10.38% | 63.38% | 54.63% | 60.23% | 8.89% |
| Capital Expenditure | 55.28% | 29.77% | 27.90% | 0.56% | -68.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -200.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.80% | -841.06% | -26.77% | -1,410.87% | -261.16% |
| Cash from Investing | 38.08% | -1,016.67% | -22.57% | -1,993.80% | -286.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.14% | -7.00% | 49.18% | 25.02% | -24.29% |
| Issuance of Common Stock | -98.80% | -98.78% | -98.78% | -99.40% | 109.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.30% | -99.28% | -99.12% | -99.69% | 110.00% |
| Foreign Exchange rate Adjustments | -112.70% | -405.72% | 187.40% | 120.44% | 155.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -291.93% | -301.55% | -434.49% | -220.92% | -15.85% |